Balthaser Kevin 4
4 · Aclaris Therapeutics, Inc. · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Aclaris (ACRS) CFO Kevin Balthaser Receives Shares via RSU Vesting
What Happened
Kevin Balthaser, Chief Financial Officer of Aclaris Therapeutics (ACRS), had 22,025 restricted stock units (RSUs convert/vest) settle into common shares on February 3, 2026. To satisfy tax withholding, 6,449 of those shares were withheld (disposed) at $3.47 per share for a withholding amount of $22,378, leaving a net receipt of 15,576 shares. This was a vesting/settlement of an equity award rather than an open-market buy or sell.
Key Details
- Transaction date: February 3, 2026; Form 4 filed February 5, 2026 (timely within SEC reporting window).
- Conversion/settlement: 22,025 RSUs converted to 22,025 shares (reported as derivative conversion).
- Tax withholding: 6,449 shares withheld at $3.47/share = $22,378 paid to cover taxes (code F).
- Net shares delivered to insider: 15,576 shares (22,025 − 6,449).
- Footnotes: F1–F3 indicate these were RSUs (one share per unit), shares were withheld to satisfy tax withholding, and the award vests in four equal annual installments beginning Feb 3, 2026 (this transaction reflects one installment).
- Shares owned after transaction: not stated in the filing.
Context
This was a routine RSU vesting and cashless tax withholding, not an open-market sale or purchase. For retail investors, vesting/withholding transactions are common compensation events and do not by themselves signal trading intent. The filing appears timely and no 10b5-1 plan or late-filing flag is indicated.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-03+22,025→ 192,204 total - Tax Payment
Common Stock
[F2]2026-02-03$3.47/sh−6,449$22,378→ 185,755 total - Exercise/Conversion
Restricted Stock Units
[F1][F3]2026-02-03−22,025→ 66,075 total→ Common Stock (22,025 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
- [F3]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.